Janiczek Wealth Management’s GSK GSK Stock Holding History

Janiczek Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$41.7K	Buy	1,082 +177	+20%	+$7.45K	0.01%	434
2024 Q1	$38.9K	Hold	905	–	–	0.01%	448
2023 Q4	$33.6K	Sell	905 -30	-3%	-$1.08K	0.01%	464
2023 Q3	$34.1K	Sell	935 -1,061	-53%	-$37.7K	0.01%	427
2023 Q2	$71.3K	Buy	1,996 +117	+6%	+$4.2K	0.02%	265
2023 Q1	$71K	Buy	1,879 +964	+105%	+$33.7K	0.02%	261
2022 Q4	$32.2K	Buy	915 +304	+50%	+$10.1K	0.01%	379
2022 Q3	$18K	Buy	611 +321	+111%	+$12.2K	0.01%	466
2022 Q2	$15K	Sell	290 -479	-62%	-$26.4K	﹤0.01%	508
2022 Q1	$42K	Buy	769 +361	+88%	+$19.6K	0.01%	329
2021 Q4	$22K	Sell	408 -25	-6%	-$1.3K	0.01%	460
2021 Q3	$21K	Buy	433 +6	+1%	+$301	0.01%	448
2021 Q2	$21K	Buy	427 +203	+91%	+$9.75K	0.01%	414
2021 Q1	$10K	Buy	224 +150	+203%	+$6.81K	﹤0.01%	529
2020 Q4	$3K	Hold	74	–	–	﹤0.01%	651
2020 Q3	$4K	Hold	74	–	–	﹤0.01%	381
2020 Q2	$4K	Buy	+74	New	+$3.8K	﹤0.01%	202

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Janiczek Wealth Management's GSK Position: Q2 2024 in Review

Janiczek Wealth Management increased its GSK (GSK) stake by 20% in Q2 2024, buying an estimated $7.45K and bringing the position to 1,082 shares worth $41.7K. The position accounts for 0.01% of the portfolio, ranked #434.

Janiczek Wealth Management first reported a position in GSK in Q2 2020 and has held it in 17 quarters since. The position peaked at $71.3K in Q2 2023. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

Janiczek Wealth Management held 1,082 shares of GSK worth $41.7K as of Q2 2024.
Janiczek Wealth Management bought 177 GSK shares in Q2 2024, an estimated $7.45K.
GSK made up 0.01% of Janiczek Wealth Management's portfolio in Q2 2024, its #434 holding.
Janiczek Wealth Management first reported a position in GSK in Q2 2020 and has held it in 17 quarters since.
Janiczek Wealth Management's GSK position peaked at $71.3K in Q2 2023.
884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.